Phillips 66 ( PSX) target raised at Oppenheimer to $55, Oppenheimer said. Outlook improved. Outperform rating. Questcor ( QCOR) estimates, target cut at BofA/Merrill. Shares of QCOR now seen reaching $45, according to Bank of America/Merrill Lynch. Estimates also reduced, following AET changes for Acthar. Buy rating. Questcor Pharmaceuticals numbers lowered at Oppenheimer. Shares of QCOR now seen reaching $65, Oppenheimer said. Estimates also lowered on revision of Acthar coverage. Outperform rating. Wyndham ( WYN) estimates, target upped at Lazard. WYN estimates were boosted through 2013, Lazard said. Company is likely to buy back more stock. Buy rating and new $63 price target. >To submit a news tip, email: firstname.lastname@example.org.